Abstract
The p53 protein is well-known for its tumour suppressor function. The p53-MDM2 negative feedback loop constitutes the core module of a network of regulatory interactions activated under cellular stress. In normal cells, the level of p53 proteins is kept low by MDM2, i.e. MDM2 negatively regulates the activity of p53. In the case of DNA damage, the p53-mediated pathways are activated leading to cell cycle arrest and repair of the DNA. If repair is not possible due to excessive damage, the p53-mediated apoptotic pathway is activated bringing about cell death. In this paper, we give an overview of our studies on the p53-MDM2 module and the associated pathways from a systems biology perspective. We discuss a number of key predictions, related to some specific aspects of cell cycle arrest and cell death, which could be tested in experiments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alberts B, Johnson A, Lewis J, Raff M, Roberts K and Walter P 2002 Molecular biology of the cell (London: Garland Science)
Bagci E Z, Vodovotz Y, Billiar T R, Ermentrout G B and Bahar I 2006 Bistability in apoptosis: Roles of Bax, Bcl-2 and mitochondrial permeability transition pores; Biophys. J. 90 1546–1559
Ciliberto A, Novak B and Tyson J J 2005 Steady state and oscillations in the p53/Mdm2 network; Cell Cycle 4 488–493
Dotto G P 2000 p21WAF1/CIP1: more than a break to the cell cycle; Biochem. Biophys. Acta. 1471 M43–M56
Fodde R and Smits R 2002 A matter of dosage; Science 298 761–766
Fussenegger M, Bailey J E and Varner J 2000 A mathematical model of caspase function in apoptosis; Nat. Biotechnol. 18 768–774
Gartel A L and Tyner A L 2002 The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis; Mol. Cancer Therapeut. 1 639–649
Ghosh B and Bose I 2005 Gene copy number and cell cycle arrest; Phys. Biol. 3 29–36
Hengartner M O 2000 The biochemistry of apoptosis; Nature (London) 407 770–776
Hohenstein P 2004 tumour suppressor genes — one hit can be enough; PLoS Biol. 2 0165–0166
Javelaud D and Besançon F 2002 Inactivation of p21WAF1 sensitizes cells to apoptosis via an increae of both p14 ARF and p53 Levels and an alteration of the Bax/Bcl-2 Ratio; J. Biol. Chem. 277 37949–37954
Knudson A G 1971 Mutation and cancer: statistical study of retinoblastoma; Proc. Natl. Acad. Sci. USA 68 820–823
Lahav G, Rosenfeld N, Segal A, Geva-Zatorsky W, Levine A J, Elowitz M B and Alon U 2004 Dynamics of the p53-Mdm2 feedback loop in individual cells; Nat. Genet. 16 147–150
Lev Bar-Or R, Maya R, Segal L A, Alon U, Levine A J and Ures M 2000 Generation of oscillations in the p53-Mdm2 feedback loop: a theoretical and experimental study; Proc. Natl. Acad. Sci. USA 97 11250–11255
Ma L, Wagner J, Rice J J, Hu W, Levine A J and Stolovitzky G A 2005 A plausible model for the digital response of p53 to DNA damage; Proc. Natl. Acad. Sci. USA 102 14266–14271
Novak B and Tyson J J 1993 Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos; J. Cell Sci. 106 1153–1168
Novak B and Tyson J J 2003 Modeling the controls of the eukaryotic cell cycle; Biochem. Soc. Trans. 31 1526–1529
Sha W, Moore J, Chen K, Lassaletta A D, Yi C-S, Tyson J J and Sible J C 2003 Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts; Proc. Natl. Acad. Sci. USA 100 975–980
Song W-J, Sullivan M G, Legare R D, Hutchings S, Xiaolian T, Kufrin D, Ratajczak J, Resende I C et al 1999 Haploinsufficiency of CBFA2 causes familiar thrombocytopenia with propensity to develop acute myelogenous leukaemia; Nat. Genet. 23 166–175
Tiana G, Jensen M H and Sneppen K 2002 Time delay as a key to apoptosis induction in the p53 network; Eur. Phys. J. B 29 135–140
Tovar C, Rosinski J, Filipovic Z, Higgins B, Kolinsky K, Hilton H, Zhao X, Vu B T, Qing W et al 2006 Small-molecule MDM2 antagoninsts reveal aberrant p53 signaling in cancer: Implications for therapy; Proc. Natl. Acad. Sci. USA 103 1889–1893
Tyson J J, Chen K and Novak B 2001 Network dynamics and cell physiology; Nat. Rev. Mol. Cell. Biol. 2 908–916
Vassilev L T et al 2004 In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2; Science 303 1889–1893
Venkatachalam S, Shi Y P, Jones S N, Vogel H, Bradley A and Pinkel D 1998 Retention of wild-tye p53 in tumours from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation; EMBO J. 17 4657–4667
Vogelstein B, Lane D and Levine A J 2000 Surfing the p53 network; Nature (London) 408 820–823
Wagner J, Ma L, Rice J J, Hu W, Levine A J and Stolovitzy G A 2005 p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback; IEEE Proc. Syst. Biol. 152 109–118
Zhang Z, Wang H, Li M, Agrawal S, Chen X and Zhang R 2004 MDM2 Is a Negative Regulator of p21WAF1/CIP, Independent of p53; J. Biol. Chem. 279 16000–16006
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bose, I., Ghosh, B. The p53-MDM2 network: from oscillations to apoptosis. J Biosci 32 (Suppl 1), 991–997 (2007). https://doi.org/10.1007/s12038-007-0103-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-007-0103-3